WB
H M R Mk
Endogenous
210
Rabbit IgG
#Q8TEM1
23225
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human, Mouse, Rat, Monkey
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro290 of human NUP210 protein.
Background
The nuclear pore complex (NPC) is a multi-subunit protein channel that spans the nuclear envelope and is responsible for the nucleocytoplasmic trafficking of RNA, proteins, and ribonucleoproteins (1,2). Nucleoporin 210 kDa (NUP210), also referred to as nuclear pore glycoprotein 210 (gp210), is one of the three integral membrane proteins of the NPC that have been shown to link the complex to the nuclear envelope (3,4). NUP210 is recruited in later stages of the nuclear pore assembly and is expressed in a cell-type specific manner (5). NUP210 expression has been shown to be induced during myogenic and neural differentiation, and its addition to NPCs is needed for activation of essential cell differentiation genes (6). It has also been shown that NUP210 is required for proper muscle structural gene expression at NPCs by acting as a scaffold for the Mef2C transcriptional complex (7). More recently, NUP210 was identified as a metastasis susceptibility gene for estrogen receptor-positive breast cancer (8).
- Raices, M. and D'Angelo, M.A. (2017) Curr Opin Cell Biol 46, 26-32.
- Xu, S. and Powers, M.A. (2009) Semin Cell Dev Biol 20, 620-30.
- Stavru, F. et al. (2006) J Cell Biol 173, 509-19.
- Stavru, F. et al. (2006) J Cell Biol 173, 477-83.
- Olsson, M. et al. (2004) Exp Cell Res 292, 359-70.
- D'Angelo, M.A. et al. (2012) Dev Cell 22, 446-58.
- Raices, M. et al. (2017) Dev Cell 41, 540-554.e7.
- Amin, R. et al. (2021) Nat Commun 12, 7216.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.